We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointments to the Clinical Advisory Board

18 Dec 2012 07:00

RNS Number : 7342T
Surgical Innovations Group PLC
18 December 2012
 



 

 

Surgical Innovations Group plc

("SI" or the "Company")

 

Appointments to the Clinical Advisory Board

 

Surgical Innovations Group plc (AIM: SUN), a designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of Colorectal consultant surgeon John Griffith and Neurosurgeon Jake Timothy to its Clinical Advisory Board ('CAB') with immediate effect.

 

John Griffith, BM, BS, FRCS, is a Consultant Colorectal and General Surgeon specialising in colorectal surgery including inflammatory bowel disease and functional disorders, as well as laparoscopic general surgical procedures including cholecystectomy and hernia operations. He graduated from the University of Nottingham in 1985 and completed his higher surgical training under the tutelage of some of the country's leading laparoscopic surgeons. John was awarded the status of National Trainer in laparoscopic colorectal surgery in 2008. Since this point he has performed the second highest number of training episodes on the LAPCO programme. As a dedicated trainer in his field he often runs training courses in colorectal and hernia surgery and is one of the faculties of LAPCO Training. He is also the national clinical adviser for colorectal cancer to NHS improvements and has pioneered survivorship work both at a local and national level. John is keen to work with the SI design team to develop and advance the current products further to the particular needs of colorectal surgery.

Jake Timothy, MBBS, MD, FRCS (Eng & SN), is a Consultant Neurosurgeon and Spine Surgeon specialising in the management of head trauma and the development of spinal surgery at Leeds General Infirmary. Trained at Charing Cross and Westminster Medical School he moved up to Leeds in 1996. He developed a head injury clinic with links to secondary care and charitable organisations and organised several national conferences concerning Neurotrauma, both independently and in conjunction with Trauma Audit and Research Network (TARN). Jake was a National Institute of Clinical Excellence (NICE) advisor on interspinous process distracters (X-stop) and minimally invasive XLIF procedure and an international figure regarding the training of surgeons. He has introduced many new techniques to the department with a focus on MIS.

Graham Bowland, Chief Executive Officer for Surgical Innovation, said: "We are delighted to welcome both John and Jake to the CAB. John's expertise in colorectal surgery will help us increase our awareness in this area and he is already liaising closely with our design team to develop new technologies for this specialism. Jake will be the first spinal surgeon to join SI's CAB and reinforces our strategy to transfer our technology into new areas of the body. Our CAB now consists of 11 extremely experienced surgeons with differing fields of speciality allowing SI to develop products to suit a broad range of clinical disciplines."

 

 

- ENDS -

 

Enquiries:

 

Surgical Innovations Group plc

www.sigroupplc.com

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer

graham.bowland@surginno.co.uk

 

 

Seymour Pierce Limited

www.seymourpierce.com

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7107 8000

David Banks (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Lianne Cawthorne

Mob: 07584 391 303 or lianne.cawthorne@walbrookpr.com

 

Notes to Editors:

 

About Surgical Innovations Group plc

 

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets.

 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

 

Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

 

The Group's patented products are sold through three main channels:

 

SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.

 

OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees. Clients include Teleflex Medical, Olympus and CareFusion.

 

Industrial

 

SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

 

For more information, see www.sigrouplplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFAFMWFESELE
Date   Source Headline
22nd Apr 20243:34 pmRNSHolding(s) in Company
19th Apr 20246:25 pmRNSHolding(s) in Company
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20237:00 amRNSYear-end Trading Update
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSNotice of Interim Results
27th Jun 20223:15 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Trading Statement
25th May 20227:00 amRNSPosting of 2021 Annual Report & Accounts
9th May 202212:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSFinal Results
21st Mar 20227:00 amRNSProduct launch in partnership with CMR Surgical
10th Mar 20227:00 amRNSNotice of Annual Results
17th Jan 20227:00 amRNSYear-end Trading Update
15th Nov 20217:00 amRNSChanges to Board Structure & CFO Appointment
10th Nov 20215:43 pmRNSGrant of Options
15th Sep 20217:00 amRNSHalf-year Report
27th Aug 20217:00 amRNSNotice of Interim Results
9th Jul 20212:29 pmRNSDirector/PDMR Shareholding
22nd Jun 20215:26 pmRNSResult of AGM
22nd Jun 20217:00 amRNSAGM Trading Statement
21st Jun 20217:00 amRNSWithdrawal of AGM Resolution
21st May 20217:00 amRNSPosting of Annual Report& Accounts & Notice of AGM
25th Mar 20217:00 amRNSFinal Results
22nd Mar 20217:00 amRNS3-year Exclusive UK distribution agreement
8th Mar 20217:00 amRNSNotice of annual results
15th Feb 20217:00 amRNS5-year USA distribution agreement
9th Feb 20217:00 amRNSLaunch of the Green Surgery Challenge
8th Jan 20217:00 amRNSDistalmotion’s Dexter Robot receives CE Mark
7th Jan 20217:00 amRNSFuture board change
21st Dec 20207:00 amRNSTrading update
17th Dec 20207:00 amRNSUS distribution agreement signed with Adler
7th Dec 20203:00 pmRNSReplacement of Auditor
2nd Dec 20207:00 amRNSProduct launch for Cellis Breast
25th Nov 20207:00 amRNSCentre for Sustainable Healthcare collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.